Due to the emergence of cephalothin-and gentamicin-resistant Klebsiella pneumoniae at this institution, we investigated the in vitro activity of two new cephalosporin compounds-cefoxitin and cefamandole. Whereas both drugs were active against cephalothin-and gentamicin-susceptible isolates of Klebsiella, only cefoxitin exhibited significant activity against cephalothin-and gentamicin-resistant isolates. Seventeen of 20 (85%) of the cephalothin-and gentamicin-resistant isolates were inhibited by <12.5 ,g of cefoxitin per ml. The minimum bactericidal concentration in broth of representative isolates equaled the agar dilution minimum inhibitory concentration. Kirby-Bauer disk susceptibility testing correlated well with the agar dilution minimum inhibitory concentration. Cephalothin and cefamandole resistance of isolates could be correlated with antibiotic degradation by (8-lactamase. Cephalothin 
,8-lactamase degradation of cefoxitin was detected. Growth curves with antibiotics indicated rapid killing of cephalothin-and gentamicin-resistant isolates by cefoxitin.
Emergence of multiply antibiotic-resistant Klebsiella pneumoniae has become a serious therapeutic problem at this institution and at others in recent years (10) . The ongoing epidemic of Klebsiella infections at this hospital with multidrug resistance, including cephalothin and gentamicin, is due to three serotypes: 2, 21, and 22. Because of the broad resistance of these organisms, we investigated the in vitro activity of two new cephalosporin compounds against these multiply resistant Klebsiella.
Cefoxitin, a cephamycin derivative structurally related to the cephalosporins, is active against Klebsiella and is resistant to ,13lacta-mase degradation (8) . Cefamandole, a new cephalosporin, is reported to show greater activity in vitro against Klebsiella than currently available cephalosporins (3) . These new antibiotics were compared to cephalothin in vitro to assess their relative effectiveness against cephalothin-and gentamicin-susceptible and -resistant clinical isolates ofKlebsiella. Gentamicin resistance. For the purpose of this study, resistance to gentamicin was detected by confluent growth to 10-pg gentamicin disks by BauerKirby testing. This was confirmed by growth from 104 to 108 organisms per ml in Mueller-Hinton broth containing 10 p.g of gentamicin per ml, with viability subsequently confirmed by growth on antibioticfree Mueller-Hinton agar. All isolates had gentamicin MICs >6.25 ,ug/ml, with the mean MIC to gentamicin of 18.7 ltg/ml.
MATERIALS AND METHODS

RESULTS
Cefamandole and cefoxitin inhibited the cephalothin-and gentamicin-susceptible isolates as shown in Fig. 1 . All strains were inhibited in the agar dilution studies by 512.5 ,g of each of the three cephalosporin compounds per ml. In Bauer-Kirby susceptibility testing, the zone of inhibition was >18 mm for all isolates with either cephalothin, cefamandole, or cefoxitin disks.
However, cefoxitin was the only antibiotic with significant activity against cephalothinand gentamicin-resistant isolates (Fig. 2) . The agar dilution MIC was s50 ,ug of cefoxitin per ml for all isolates, and 17 of 20 (85%) isolates were inhibited by s 12.5 ,ug of cefoxitin per ml. In Bauer-Kirby susceptibility testing, cefoxitin produced zones of inhibition of : 18 mm against 18 isolates (90%), with an agar dilution MIC s25 pg/ml. In contrast, cefamandole and cephalothin inhibited only two isolates (10%) at O50 ,g/ml, and the other isolates were not inhibited by 100 ,ug of either drug per ml. In Bauer-Kirby The microbiological assay demonstrated striking cloverleaf patterns with all 20 cephalothin-resistant isolates to cephalothin and cefamandole, but not cefoxitin. Eight of ten cephalothin-susceptible isolates also produced cloverleaf patterns (always to a less pronounced degree than the cephalothin-resistant isolates) with cephalothin and cefamandole. Again, zones around the cefoxitin disks were circular, indicating absence of (3-lactamase degradation.
Growth curves and antibiotic inactivation. Cephalothin and cefamandole inhibited bacterial growth only transiently, with the antibiotic rapidly inactivated in the culture (Fig. 3) . In 
DISCUSSION
Cefoxitin is demonstrably effective in vitro when tested against our cephalothin-and gentamicin-resistant Klebsiella. Cefamandole appers to be ineffective in vitro against those same multiply resistant strains. Cefoxitin has previously been reported to be effective in vitro against cephalothin-resistant Klebsiella (7). Cefamandole has been reported to show promising in vitro activity against cephalothin-susceptible Klebsiella, but is only minimally effective against cephalothin-resistant isolates (7) .
The indifference of cefoxitin to ,B-lactamase degradation appears to be the major factor contributing to the drug's efficacy against our multiply resistant Klebsiella. Cefamandole and cephalothin were readily degraded by the (3 lactamase of our resistant isolates. In contrast, ,3lactamase activity failed to significantly degrade cefoxitin according to the acidometric assay or during growth curves with the antibiotic.
No &3lactamase degradation of cefoxitin occurred with the microbiological cloverleaf procedure to Findell and Sherris (4) , which offers good conditions for enzyme induction due to exposure of organisms to graduations of the diffusing antibiotic.
Resistance to cefoxitin by Klebsiella is readily induced in vitro by exposure to subinhibitory concentrations in an incremental fashion. However, the resistance appears to be intrinsic in nature and not due to inactivation by (8-lactamase (6) .
Cefoxitin achieves serum and urine levels comparable to those ofcephalothin, and toxicity appears minimal (5) . If clinical trials in progress here confirm the efficacy of cefoxitin against our multiply antibiotic-resistant Klebsiella, cefoxitin will be a welcome new antibiotic for therapy of these troublesome infections.
